Skip to content
Screener

Lucid Group, Inc. LCID Business Segments — SG&A

Similar metrics at other companies

Silicon Laboratories logo
SLABReportable Segment — SG&A
$55.49M+33.3%
Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — SG&A
$124M-6.8%
VGN
VGNTReportable Segment — SG&A
$97M-7.6%
BridgeBio Pharma logo
BBIOReportable Segment — SG&A
$163.9M+54.1%
QXO, Inc. logo
QXOReportable Segment — SG&A
$457.8M+1,792%
Agios Pharmaceuticals logo
AGIOReportable Segment — SG&A
$51.55M+12.4%

Other financials

Income statement

See full
Revenue$405.3M+56.2%
Gross profit-$426.7M-56.7%
Operating income-$1.1B-34.8%
Net income-$1.0B-91.8%
EPS (diluted)-$3.30-1,079%

Balance sheet

See full
Cash & equivalents$732.6M-59.2%
Total debt$3.4B+22.6%
Total equity-$1.1B-144%
Total assets$7.7B-13.2%

Cash flow

See full
Operating cash flow-$1.2B-47.2%
CapEx$253.8M+39.0%
Free cash flow-$1.5B-45.7%

Valuation

See full
Market cap$2.75B-59.0%
Enterprise value$5.38B-29.8%
P/S1.8×-5.5×

Profitability

See full
Gross margin-96.6%-2.6pp
Operating margin-263.6%-40.8pp
Net margin-249.2%+2.2pp
FCF margin-330.4%+2.1pp

Returns & leverage

See full
Return on equity-117.6%+947pp
Debt / equity5.4×+4.8×
Current ratio1.1×-1.4×

Where this comes from

Reported directly by Lucid Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Lucid Group, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-030517
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cost of revenue - LCNRV(237,853)(151,636)
Cost of revenue - provision for warranty(19,111)(12,312)
Research and development expenses(335,670)(251,246)
Selling, general, and administrative expenses(304,176)(212,175)
Workforce reduction charges(37,934)
Change in fair value of common stock warrant liability12,861
Change in fair value of equity securities(10,221)(13,453)
Change in fair value of derivative liabilities associated with redeemable convertible preferred stock (related party)7,375281,700

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Lucid Group, Inc.'s business segments — SG&A?
Lucid Group, Inc. (LCID) reported business segments — SG&A of $304.18M in Q1 2026.
How has Lucid Group, Inc.'s business segments — SG&A changed year-over-year?
Lucid Group, Inc.'s business segments — SG&A increased by 43.4% year-over-year, from $212.18M to $304.18M.
What is the long-term trend for Lucid Group, Inc.'s business segments — SG&A?
Over 3 years (2022 to 2025), Lucid Group, Inc.'s business segments — SG&A has grown at a 12.1% compound annual growth rate (CAGR), from $734.57M to $1.03B.
What does business segments — SG&A mean?
This captures the operating expenses related to the management, marketing, and administrative support functions of the business segment. It reflects the overhead costs required to support the segment's commercial operations and corporate infrastructure.

Ask your AI about Lucid Group, Inc.'s business segments — sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude